Phathom Pharmaceuticals Financial Overview
Phathom Pharmaceuticals's market cap is currently $1.09B. The company's EPS TTM is $-0.41; its P/E ratio is -4.27; Phathom Pharmaceuticals is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
